Seipel, K.; Frey, M.; Nilius, H.; Akhoundova, D.; Banz, Y.; Bacher, U.; Pabst, T.
Low-Frequency PPM1D Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell Lymphoma. Curr. Oncol. 2023, 30, 10463-10476.
https://doi.org/10.3390/curroncol30120762
AMA Style
Seipel K, Frey M, Nilius H, Akhoundova D, Banz Y, Bacher U, Pabst T.
Low-Frequency PPM1D Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell Lymphoma. Current Oncology. 2023; 30(12):10463-10476.
https://doi.org/10.3390/curroncol30120762
Chicago/Turabian Style
Seipel, Katja, Michèle Frey, Henning Nilius, Dilara Akhoundova, Yara Banz, Ulrike Bacher, and Thomas Pabst.
2023. "Low-Frequency PPM1D Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell Lymphoma" Current Oncology 30, no. 12: 10463-10476.
https://doi.org/10.3390/curroncol30120762
APA Style
Seipel, K., Frey, M., Nilius, H., Akhoundova, D., Banz, Y., Bacher, U., & Pabst, T.
(2023). Low-Frequency PPM1D Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell Lymphoma. Current Oncology, 30(12), 10463-10476.
https://doi.org/10.3390/curroncol30120762
